A pilot study of Susceptibility testing based Fourth-line Helicobacter pylori eradication therapy
Not Applicable
Completed
- Conditions
- Helicobacter pylori infection
- Registration Number
- JPRN-UMIN000025765
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
A patient who don't agree for endoscopy and susceptible testing as own expense medical care before eradication therapy. Past history of allergy or side effect requiring treatment for the drugs used in this study. Pregnancy or lactation. A patient with brain and spinal cord disease. A patient with infectious mononucleosis. Severe liver dysfunction, severe renal dysfunction, severe heart dysfunction. Patients who are disqualified for the study by physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication rate assessed by urea breath test more than 8 weeks after treatment
- Secondary Outcome Measures
Name Time Method Safety evaluated by side effects questionnaire filled by patients